Material Agreements

TCW STRATEGIC INCOME FUND INC entered into Dealer Manager Agreement with UBS Securities LLC (effective 2026-02-19).

“On February 19, 2026, TCW Strategic Income Fund, Inc. (NYSE: TSI) (the “Fund”) entered into a dealer manager agreement (the “Dealer Manager Agreement”) by and among the Fund, TCW Investment Management Company LLC and UBS Securities LLC”

GILEAD SCIENCES, INC. entered into Merger Agreement with Arcellx, Inc. (effective 2026-02-22).

“On February 22, 2026, Gilead Sciences, Inc., a Delaware corporation (“ Parent ” or “ Gilead ”), entered into an Agreement and Plan of Merger (the “ Merger Agreement ”), among Parent, Arcellx, Inc., a Delaware corporation (the “ Company ”), and Ravens Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“ Purchaser ”).”

EMPIRE PETROLEUM CORP entered into Promissory Note with Phil E. Mulacek valued at $3,000,000 (effective 2026-02-19).

“On February 19, 2026, Empire Petroleum Corporation (the “Company”) issued that certain Promissory Note in the aggregate principal amount of $3,000,000 (the “Note”) to Phil E. Mulacek.”

PENN Entertainment, Inc. entered into Cooperation Agreement with HG Vora Capital Management, LLC and certain related parties (collectively, "HG Vora") (effective 2026-02-22).

“On February 22, 2026, PENN Entertainment, Inc. (the “Company”) entered into a cooperation agreement (the “Cooperation Agreement”) with HG Vora Capital Management, LLC and certain related parties (collectively, “HG Vora”).”

Algorhythm Holdings, Inc. entered into Secured Pre-Paid Purchase #4 with Streeterville Capital, LLC valued at $10,355,000 (effective 2026-02-17).

“On February 17, 2026, Algorhythm Holdings, Inc. (the “Company”) entered into Secured Pre-Paid Purchase #4 with Streeterville Capital, LLC, a Utah limited liability company (“Streeterville”), under that certain securities purchase agreement (the “Securities Purchase Agreement”), dated August 21, 2025, between the Company and Streeterville.”

TYSON FOODS, INC. entered into Supplemental Indenture with The Bank of New York Mellon Trust Company, N.A. valued at $500,000,000 (effective 2026-02-20).

“The Company issued the Notes under an indenture dated as of June 1, 1995 (the “Base Indenture”) between the Company and The Bank of New York Mellon Trust Company, N.A. (as successor to JPMorgan Chase Bank, N.A. (formerly The Chase Manhattan Bank, N.A.)), as trustee (the “Trustee”), as amended and supplemented by a supplemental indenture dated as of February 20, 2026 for the Notes (the “Supplemental Indenture” and, together with the Base Indenture, the “Indenture”), by and between the Company and the Trustee.”

AMERICAN STATES WATER CO amended Equity Distribution Agreement with Wells Fargo Securities, LLC, Janney Montgomery Scott LLC, RBC Capital Markets, LLC, Siebert Williams Shank & Co., LLC, and Huntington Securities, Inc. (effective 2026-02-20).

“On February 20, 2026, American States Water Company (the “Company”) entered into an amendment (the “Amendment”) to the Equity Distribution Agreement, dated February 27, 2024 (the “Original Equity Distribution Agreement” and, together with the Amendment, the “Equity Distribution Agreement”), by and among the Company and Wells Fargo Securities, LLC (“Wells Fargo”), Janney Montgomery Scott LLC (“JMS”), RBC Capital Markets, LLC (“RBC”), and Siebert Williams Shank & Co., LLC in their capacities as sales agents (collectively, the “Sales Agents”), in order to replace JMS as Sales Agent thereunder with Huntington Securities, Inc. (“Huntington”).”

EXELON CORP entered into 4.950% Notes due 2036 valued at $775 million (effective 2026-02-20).

“On February 20, 2026, Exelon Corporation (the “Company”) issued and sold $775 million in aggregate principal amount of its 4.950% Notes due 2036 (the “Notes”).”

CARNIVAL PLC entered into Unification Agreement with Carnival Corporation (effective 2026-02-20).

“On February 20, 2026, Carnival Corporation and Carnival plc entered into a unification agreement (the “Unification Agreement”).”

ORAMED PHARMACEUTICALS INC. entered into Warrant Agreement with Scilex Holding Company (effective 2026-02-19).

“On February 19, 2026, Oramed Pharmaceuticals Inc. (the “Company”) entered into a Warrant Agreement (the “Warrant Agreement”) with Scilex Holding Company (“Scilex”).”

ASHFORD HOSPITALITY TRUST INC entered into Agreement of Purchase and Sale with Kolter Group Acquisitions LLC valued at $96 million (effective 2025-12-12).

“On December 12, 2025, St. Petersburg Florida Hotel Limited Partnership and Ashford TRS Lessee II LLC (together, “Seller”), indirect wholly owned subsidiaries of Ashford Hospitality Trust, Inc. (the “Company”), entered into an Agreement of Purchase and Sale (the “Agreement”) with Kolter Group Acquisitions LLC (“Purchaser”), for the sale of Hilton St. Petersburg Bayfront located in St. Petersburg, Florida (the “Hotel”) for $96 million in cash, subject to customary prorations and adjustments (the “Purchase Price”).”

NISSAN AUTO LEASING LLC II entered into Underwriting Agreement with BofA Securities, Inc. valued at $1,250,000,000 (effective 2026-02-18).

“On February 18, 2026, Nissan Auto Leasing LLC II (“NALL II”) and Nissan Motor Acceptance Company LLC (“NMAC”) entered into an Underwriting Agreement, dated as of February 18, 2026 (the “Underwriting Agreement”), with BofA Securities, Inc., on behalf of itself and as a representative of the several underwriters, for the issuance and sale of notes of Nissan Auto Lease Trust 2026-A (the “Issuing Entity”) in the following classes: Class A-1 Notes, Class A-2a Notes, Class A-2b Notes, Class A-3 Notes, Class A-4 Notes, Class B Notes and Class C Notes (collectively, the “Notes”).”

CARMAX AUTO FUNDING LLC entered into Underwriting Agreement with Barclays Capital Inc., as representative of the several underwriters named therein valued at $750,000,000 aggregate principal balance (effective 2026-02-18).

“On February 18, 2026, CarMax Business Services, LLC (“CarMax Business Services”) and CarMax Auto Funding LLC (the “Depositor”) entered into an Underwriting Agreement with Barclays Capital Inc., as representative of the several underwriters named therein (collectively, the “Underwriters”), whereby each of the Underwriters has severally agreed to purchase $750,000,000 aggregate principal balance of various classes of Asset-backed Notes to be issued by CarMax Select Receivables Trust 2026-A (the “Issuing Entity”)”

Cohen & Co Inc. entered into Equity Distribution Agreement with Northland Securities, Inc. (trade name Northland Capital Markets) and Cohen & Company Securities, LLC valued at up to $75,000,000 (effective 2026-02-20).

“On February 20, 2026, Cohen & Company Inc., a Maryland corporation (the “Company”), entered into an Equity Distribution Agreement (the “Agreement”) with Northland Securities, Inc. (trade name Northland Capital Markets) (“Northland”) and Cohen & Company Securities, LLC (“Cohen Securities”), as sales agents (Cohen Securities and Northland, together, the “Sales Agent”), relating to the issuance and sale from time to time by the Company (the “ATM Program”), through the Sales Agents, of shares of the Company’s common stock, par value $0.01 per share, having an aggregate offering price of up to $75,000,000 (the “Shares”).”

SANTANDER DRIVE AUTO RECEIVABLES LLC entered into Underwriting Agreement with Citigroup Global Markets Inc., on behalf of itself and as representative of the several underwriters (effective 2026-02-18).

“On February 18, 2026, Santander Drive Auto Receivables LLC (“Santander Drive”) and Santander Consumer USA Inc. (“SC”) entered into an Underwriting Agreement (the “Underwriting Agreement”) with Citigroup Global Markets Inc., on behalf of itself and as representative of the several underwriters (collectively, the “Underwriters”), for the sale of the following notes to be issued by Santander Drive Auto Receivables Trust 2026-1 (the “Issuer”): the Class A-2 4.04% Auto Loan Asset Backed Notes, the Class A-3 3.93% Auto Loan Asset Backed Notes, the Class B 4.07% Auto Loan Asset Backed Notes, the Class C 4.26% Auto Loan Asset Backed Notes and the Class D 4.75% Auto Loan Asset Backed Notes (collectively, the “Publicly Registered Notes”).”

Zurn Elkay Water Solutions Corp amended Amendment No. 3 with UBS AG, Stamford Branch; JPMorgan Chase Bank, N.A. valued at increases the capacity of the revolving credit facility under the Credit Agreement from $200 million (effective 2026-02-19).

“On February 19, 2026 (the "Effective Date"), Zurn Elkay Water Solutions Corporation's (the "Company") subsidiaries ZBS Global, Inc., Zurn Holdings, Inc., Zurn LLC, and EMC Water LLC, as Borrowers (collectively, the "Borrowers"), the other loan parties thereto, the lenders from time to time party thereto, and UBS AG, Stamford Branch, as former administrative agent and former collateral agent, and JPMorgan Chase Bank, N.A., as successor administrative agent and successor collateral agent, entered into Amendment No. 3 (the "Amendment") to the Fourth Amended and Restated First Lien Credit Agreement, dated as of October 4, 2021 (the "Credit Agreement").”

OFS Capital Corp terminated Revolving Credit and Security Agreement with BNP Paribas (effective 2026-02-18).

“On February 18, 2026, in connection with the closing of the Natixis Credit Facility, the Borrower repaid in full all outstanding obligations due and terminated all commitments under that certain Revolving Credit and Security Agreement, dated as of June 20, 2019 (as amended), by and among the Borrower, the lenders from time to time party thereto, BNP Paribas, as administrative agent, OFSCC-FS Holdings, LLC, as equityholder, the Company, as servicer, Citibank, N.A., as collateral agent and Virtus Group, LP, as collateral administrator (the “BNP Facility”).”

OFS Capital Corp entered into Credit Agreement with Natixis, New York Branch valued at $80,000,000 (effective 2026-02-18).

“On February 18, 2026, OFSCC-FS, LLC (the “Borrower”), an indirect wholly owned subsidiary of OFS Capital Corporation (the “Company”), entered into a revolving credit and security agreement (the “Credit Agreement”) with the lenders from time to time party thereto, Natixis, New York Branch, as administrative agent (the “Administrative Agent”), OFSCC-FS Holdings, LLC, a wholly owned subsidiary of the Company, as equityholder (in such capacity, the “Equityholder”), the Company, as servicer (in such capacity, the “Servicer”), Virtus Group, LP, as collateral administrator (in such capacity, the “Collateral Administrator”) and Citibank, N.A. (the “Bank”), as collateral agent (in such capacity, the “Collateral Agent”), which provides for borrowings in an aggregate principal amount of up to $80,000,000 (the “Natixis Credit Facility”).”

ATOSSA THERAPEUTICS, INC. terminated Prior Agreement with Jefferies LLC (effective 2026-02-19).

“On February 19, 2026, the Company delivered written notice to Jefferies LLC indicating that it is terminating the Open Market Sale Agreement SM (the “Prior Agreement”) by and between the Company and Jefferies LLC, dated November 19, 2024, effective as of February 19, 2026.”

ATOSSA THERAPEUTICS, INC. entered into Sales Agreement with Rodman & Renshaw LLC valued at up to $50,000,000 (effective 2026-02-20).

“On February 20, 2026, Atossa Therapeutics, Inc. (the “Company”) entered into the At the Market Offering Agreement, dated February 20, 2026 (the “Sales Agreement”), with Rodman & Renshaw LLC (the “Sales Agent”), pursuant to which the Company may offer and sell from time to time up to $50,000,000 of shares of the Company’s common stock”

Wheeler Real Estate Investment Trust, Inc. entered into Participation Rights and Expense Reimbursement Letter Agreement with Investors (effective 2026-02-19).

“In connection with the A&R Warrants, on February 19, 2026, the Company and the Investors entered into a Participation Rights and Expense Reimbursement Letter Agreement (the “Letter Agreement”).”

Wheeler Real Estate Investment Trust, Inc. entered into Excepted Holder Agreement with Investors (effective 2026-02-19).

“On February 19, 2026, the Company and the Investors entered into an Excepted Holder Agreement with respect to such limits (the "Excepted Holder Agreement").”

Wheeler Real Estate Investment Trust, Inc. amended Amended and Restated Registration Rights Agreement with Investors (effective 2026-02-19).

“In connection with the A&R Warrants, on February 19, 2026, the Company and the Investors entered into an Amended and Restated Registration Rights Agreement (the “A&R Registration Rights Agreement”), pursuant to which the Company agreed to register the resale of shares of Common Stock underlying the A&R Warrants on a Registration Statement on Form S-11 within 45 days following the date of the A&R Registration Rights Agreement.”

Wheeler Real Estate Investment Trust, Inc. amended Amended and Restated Common Stock Purchase Warrant with affiliates of Magnetar Financial LLC and AY2 Capital LLC (effective 2026-02-19).

“On February 19, 2026, each Warrant held by the Investors was amended and restated in the form of an Amended and Restated Common Stock Purchase Warrant (together, the “A&R Warrants”).”

Sigyn Therapeutics, Inc. entered into Convertible Note Purchase Agreement with Lambda Venture Partners, LLC valued at $27,777.77 (effective 2026-02-06).

“On February 6, 2026, Sigyn Therapeutics, Inc. (the “Company”) entered into a one-year Convertible Note Purchase Agreement (the “Purchase Agreement”) with Lambda Venture Partners, LLC, in the principal amount of $27,777.77”

Sigyn Therapeutics, Inc. entered into Convertible Note Purchase Agreement with Osher Capital Partners, LLC valued at $22,222.22 (effective 2026-02-12).

“On February 12, 2026, Sigyn Therapeutics, Inc. (the “Company”) entered into a one-year Convertible Note Purchase Agreement (the “Purchase Agreement”) with Osher Capital Partners, LLC, in the principal amount of $22,222.22”

Sigyn Therapeutics, Inc. entered into Convertible Note Purchase Agreement with Brio Capital Master Fund, Ltd valued at $22,222.22 (effective 2026-02-12).

“On February 12, 2026, Sigyn Therapeutics, Inc. (the “Company”) entered into a one-year Convertible Note Purchase Agreement (the “Purchase Agreement”) with Brio Capital Master Fund, Ltd, in the principal amount of $22,222.22”

Moleculin Biotech, Inc. entered into Inducement Letter with holders of certain existing warrants valued at approximately $8.3 million (effective 2026-02-19).

“On February 19, 2026, Moleculin Biotech, Inc. (the “Company”) entered into warrant exercise inducement offer letters (each, an “Inducement Letter”) with holders of certain existing warrants (the “Holders”) to purchase up to 2,122,652 shares of Company common stock with an exercise price of $3.90 per share (the “Existing Warrants”).”

JUPITER NEUROSCIENCES, INC. amended Omnibus Amendment with YA II PN, LTD (effective 2026-02-20).

“On February 20, 2026, the Company and Yorkville entered into an Omnibus Amendment (the “Amendment”) to revise Section 1(c) of the A&R Convertible Notes, the “Monthly Payments” provision.”

HYDROFARM HOLDINGS GROUP, INC. terminated Credit Agreement with JPMorgan Chase Bank, N.A. (effective 2026-02-17).

“On February 17, 2026, Hydrofarm Holdings Group, Inc.(the "Company") entered into an agreement to terminate (the "Termination Agreement") that certain Credit Agreement, dated as of March 29, 2021, as amended, by among JPMorgan Chase Bank, N.A. ("JPMorgan"), as administrative agent, issuing bank and swingline lender, the other loan parties from time to time party thereto and the lenders from time to time party thereto (the "Revolving Credit Agreement").”

Katapult Holdings, Inc. amended Eighth Limited Waiver with Midtown Madison Management LLC, as administrative, payment and collateral agent and lender, and the lenders party thereto (effective 2026-02-13).

“On February 13, 2026, Katapult Holdings, Inc. (the “Company”) entered into the Limited Waiver (the “Eighth Limited Waiver”) to our Amended and Restated Loan and Security Agreement, dated as of June 12, 2025”

Green Thumb Industries Inc. amended Amendment No. 1 to Credit Agreement with Valley National Bank valued at $50 million (effective 2026-02-19).

“On February 19, 2026, GTI23, Inc. (the “Borrower”), a Delaware corporation and a subsidiary of Green Thumb Industries Inc., a British Columbia corporation (the “Company”) entered into Amendment No. 1 to Credit Agreement (the “Amendment”) with respect to the existing Credit Agreement, dated September 11, 2024 (as amended, the “Credit Agreement”), by and among the Borrower, certain other subsidiaries of the Company as guarantors, the lenders party thereto, and Valley National Bank, a national banking association, in its capacity as agent for the lenders.”

MSP Recovery, Inc. entered into Advance Letter with VRM MSP Recovery Partners, LLC with VRM MSP Recovery Partners, LLC valued at $0.2 million (effective 2026-02-20).

“On February 20, 2026, the Company entered into a letter agreement (the “Advance Letter”) with VRM MSP Recovery Partners, LLC (“VRM”), pursuant to which VRM agreed to make available a one-time advance of recovery proceeds of $0.2 million to be used primarily to support the Company’s accounts payables.”

MSP Recovery, Inc. entered into Hazel Letter Agreement with Hazel Partners Holdings LLC valued at $0.2 million (effective 2026-02-19).

“On February 19, 2026, MSP Recovery, Inc. (the “Company”), through its subsidiaries, entered into a letter agreement with Hazel Partners Holdings LLC (“Hazel”), in its capacity as administrative agent and lender under the Company’s existing working capital credit facility (the “Hazel Letter Agreement”) to provide $0.2 million to be used primarily for operating expenses.”

Scilex Holding Co entered into Warrant Agreement with Oramed Pharmaceuticals Inc. (effective 2026-02-19).

“On February 19, 2026, Scilex Holding Company (the “ Company ”) entered into a Warrant Agreement (the “ Warrant Agreement ”) with Oramed Pharmaceuticals Inc. (“ Oramed ”).”

TriSalus Life Sciences, Inc. entered into Underwriting Agreement with Lake Street Capital Markets, LLC (effective 2026-02-19).

“On February 19, 2026, TriSalus Life Sciences, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Lake Street Capital Markets, LLC (“LSCM”), as representative of the underwriters named therein (the “Underwriters”), relating to the public offering (the “Offering”) of 9,756,100 shares (the “Shares”) of common stock of the Company, par value $0.0001 per share (the “Common Stock”), at a price to the public of $4.10 per Share (the “Offering Price”).”

RXO, Inc. entered into 6.375% Senior Notes due 2031 Indenture with Regions Bank valued at $400,000,000 (effective 2026-02-20).

“Item 1.01. Entry Into a Material Definitive Agreement. On February 20, 2026, RXO, Inc. (the “Company”) closed its previously announced offering of $400,000,000 in aggregate principal amount of its 6.375% Senior Notes due 2031 (the “Notes”).”

INTEGRATED RAIL & RESOURCES INC. entered into Securities Purchase Agreement with Creto IRRX PIPE Investment, LLC valued at approximately $5,000,000 (effective 2026-01-23).

“On January 23, 2026 (the “Closing Date”), Integrated Rail & Resources Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with Creto IRRX PIPE Investment, LLC (the “Investor”), pursuant to which the Company agreed to sell an aggregate of 50,000 shares of its Series A Convertible Preferred Stock, par value $0.0001 per share and stated value $100.00 per share (the “Preferred Stock”), for gross proceeds of approximately $5,000,000”

OFF THE HOOK YS INC. entered into Membership Interest Purchase Agreement with Apex Marine Sales, LLC, Apex Marine Stuart LLC, Apex Marine, LLC and Apex Marine Sales Brokerage, LLC valued at $5,500,000 (effective 2026-02-13).

“On February 13, 2026, Off The Hook YS Inc., a Nevada corporation (the “Company”), entered into a Membership Interest Purchase Agreement (the “Purchase Agreement”) with Apex Marine Sales, LLC, Apex Marine Stuart LLC, Apex Marine, LLC and Apex Marine Sales Brokerage, LLC, each a Florida limited liability company (collectively, the “Sellers”), pursuant to which the Company agreed to acquire all of the issued and outstanding equity interests of the Sellers’ marine dealership, service, storage and brokerage businesses (collectively, “APEX”).”

Averin Capital Acquisition Corp. entered into Letter Agreement with officers, directors and Sponsor valued at Letter agreement among Company, officers, directors and Sponsor (effective 2026-02-18).

“● A Letter Agreement, dated February 18, 2026, by and among the Company, its officers, its directors and the Sponsor, a copy of which is attached as Exhibit 10.4 hereto and incorporated herein by reference.”

Averin Capital Acquisition Corp. entered into Registration Rights Agreement with certain security holders valued at Registration rights for security holders (effective 2026-02-18).

“● A Registration Rights Agreement, dated February 18, 2026, by and among the Company and certain security holders, a copy of which is attached as Exhibit 10.2 hereto and incorporated herein by reference.”

Averin Capital Acquisition Corp. entered into Investment Management Trust Agreement with Continental Stock Transfer & Trust Company valued at Trust agreement related to IPO proceeds (effective 2026-02-18).

“An Investment Management Trust Agreement, dated February 18, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as trustee”

Averin Capital Acquisition Corp. entered into Warrant Agreement with Continental Stock Transfer & Trust Company valued at Each whole Warrant entitling holder to purchase one Class A Ordinary Share for $11.50 per share (effective 2026-02-18).

“A Warrant Agreement, dated February 18, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent”

Averin Capital Acquisition Corp. entered into Underwriting Agreement with Deutsche Bank Securities Inc. valued at IPO of 25,000,000 units at $10.00 per unit, $250,000,000 gross proceeds (effective 2026-02-18).

“An Underwriting Agreement, dated February 18, 2026 by and between the Company and Deutsche Bank Securities Inc., as representative of the several underwriters”

Abony Acquisition Corp. I entered into Underwriting Agreement with BTIG, LLC valued at Underwriting Agreement (effective 2026-02-18).

“The Company entered into the following agreements, forms of which were previously filed as exhibits to the Registration Statement: ● An Underwriting Agreement, dated February 18, 2026, between the Company and BTIG, LLC, as representative of the underwriters named therein (the “Representative”), a copy of which is filed as Exhibit 1.1 to this Current Report on Form 8-K (this “Report”) and incorporated herein by reference”

COUSINS PROPERTIES INC entered into Supplemental Indenture with U.S. Bank Trust Company, National Association valued at $500,000,000 in aggregate principal amount of 4.875% Senior Notes due 2033 (effective 2026-02-20).

“On February 20, 2026, Cousins Properties LP (the “Operating Partnership”), the operating partnership and wholly owned subsidiary of Cousins Properties Incorporated (the “Company”), issued $500,000,000 in aggregate principal amount of 4.875% Senior Notes due 2033 (the “Notes”), which mature on March 1, 2033, pursuant to an indenture, dated as of May 8, 2024 (as amended and supplemented by a supplemental indenture (the “Supplemental Indenture”), dated as of February 20, 2026, the “Indenture”), by and among the Operating Partnership, the Company and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”).”

RELIABILITY INC entered into Settlement Agreement with Vivos Holdings, LLC; Vivos Real Estate Holdings, LLC; Naveen Doki; Silvija Valleru; Suresh Doki; Shirisha Janumpally, individually and as Trustee of Judos Trust; Kalyan Pathuri, individually and as Trustee of Igly Trust; and Federal Systems, LLC (effective 2026-02-16).

“On February 16, 2026, Reliability Incorporated, a Texas corporation, and Maslow Media Group, Inc., a Virginia corporation entered into a settlement agreement and general mutual release (“Settlement Agreement”) with Vivos Holdings, LLC; Vivos Real Estate Holdings, LLC; Naveen Doki; Silvija Valleru; Suresh Doki; Shirisha Janumpally, individually and as Trustee of Judos Trust; Kalyan Pathuri, individually and as Trustee of Igly Trust; and Federal Systems, LLC (collectively, “Respondents”).”

HASBRO, INC. amended Fourth Amended and Restated Revolving Credit Agreement with Bank of America, N.A. valued at $1,100,000,000 revolving credit facility, with potential incremental increase of $550,000,000 (effective 2026-02-20).

“Item 1.01 Entry into a Material Definitive Agreement. On February 20, 2026 (the "Effective Date"), Hasbro, Inc. (the "Company" or the "Borrower") entered into a Fourth Amended and Restated Revolving Credit Agreement (the "Amended Agreement") with Bank of America, N.A., as administrative agent, swing line lender, L/C issuer and lender, and certain other financial institutions, as L/C issuers and/or lenders.”

FIRST MID BANCSHARES, INC. amended Sixth Amended and Restated Credit Agreement with The Northern Trust Company valued at $15 million revolving loan (effective 2026-02-19).

“On February 19, 2026, First Mid Bancshares, Inc. (the “Company”) entered into a Tenth Amendment (the “Amendment”) to its Sixth Amended and Restated Credit Agreement, dated as of April 12, 2019, as amended, with The Northern Trust Company evidencing a $15 million revolving loan.”

PULTEGROUP INC/MI/ entered into Senior Notes Indenture and Supplemental Indenture with U.S. Bank Trust Company, National Association valued at $800,000,000 senior unsecured notes offering ($400,000,000 4.250% Senior Notes due 2031 and $400,000 (effective 2026-02-20).

“On February 20, 2026, PulteGroup, Inc. (the “ Company ”) completed an underwritten public offering of a total of $800.0 million aggregate principal amount of its senior unsecured notes, consisting of $400.0 million aggregate principal amount of its 4.250% Senior Notes due 2031 (the “ 2031 Notes ”) and $400.0 million aggregate principal amount of its 4.900% Senior Notes due 2036 (the “ 2036 Notes ” and, together with the 2031 Notes, the “ Notes ”), in each case, pursuant to the Company’s effective shelf registration statement on Form S-3 (File No. 333-293234), the prospectus dated February 5, 2026 contained therein, and the related prospectus supplement dated February 10, 2026.”